Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Momenta Pharmaceuticals Inc (NASDAQ:MNTA)

14.40
Delayed Data
As of Jan 23
 +0.05 / +0.35%
Today’s Change
7.86
Today|||52-Week Range
17.25
-4.32%
Year-to-Date
No recent news for Momenta Pharmaceuticals Inc.

Today’s Trading

Previous close14.35
Today’s open14.30
Day’s range14.15 - 14.60
Volume280,600
Average volume (3 months)551,679
Market cap$1.0B
Dividend yield--
Data as of 3:59pm ET, 01/23/2017

Growth & Valuation

Earnings growth (last year)+30.89%
Earnings growth (this year)+12.59%
Earnings growth (next 5 years)--
Revenue growth (last year)+71.58%
P/E ratioNM
Price/Sales10.45
Price/Book2.67

Competitors

 Today’s
change
Today’s
% change
BPMCBlueprint Medicines ...-0.17-0.53%
XLRNAcceleron Pharma Inc+0.07+0.29%
CHRSCoherus BioSciences ...+0.15+0.58%
AMAGAMAG Pharmaceuticals...-0.75-3.10%
Data as of 4:00pm ET, 01/23/2017

Financials

Next reporting dateFebruary 21, 2017
EPS forecast (this quarter)-$0.23
Annual revenue (last year)$89.7M
Annual profit (last year)-$83.3M
Net profit margin-92.93%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Craig A. Wheeler
Chief Operating Officer
Matthew P. Ottmer
Corporate headquarters
Cambridge, Massachusetts

Forecasts


Search for Jobs